Wordt geladen...
Detection of SARS-CoV-2 neutralizing antibodies with a cell-free PCR assay
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has led to more than 4 million confirmed infections worldwide and over 300,000 deaths. While Remdesivir has recently received FDA emergency use authorization for treatment of SARS-CoV-2 infection, convalescent plasma (CP) with high titers...
Bewaard in:
| Gepubliceerd in: | medRxiv |
|---|---|
| Hoofdauteurs: | , , , , , , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Cold Spring Harbor Laboratory
2020
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7302305/ https://ncbi.nlm.nih.gov/pubmed/32577696 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/2020.05.28.20105692 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|